Company intelligence / Profile preview
Curium
Paris, Francecuriumpharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Curium is the world’s leading radiopharmaceutical company specializing in both diagnostic and therapeutic nuclear medicine. It serves over 14 million patients annually across more than 60 countries. Its portfolio covers SPECT, PET tracers, cold kits, hot products, and therapeutic radioligands. The company has a strong oncology focus—especially neuroendocrine tumors and prostate cancer—and recently submitted an NDA to the FDA for its formulation of lutetium Lu177 dotatate injection targeting SSTR-positive GEP-NETs.
- Therapeutic areas
- Oncology
- Modalities
- Radiopharmaceuticals (including SPECT and PET tracers)Therapeutic radioligands (e.g., lutetium-based therapies)Diagnostic agents for nuclear imaging
- Industry
- Biotech
02
Drug pipeline
30 assets29 more assets in the full pipeline.
03
Partnerships
Not specifically listed in public sources; collaborates widely with hospitals/healthcare providers globally.
Beyond the preview
Go deeper on Curium.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Curium.